Table 1.
Clinical Characteristics of Patients with Different Anti-coagulation Method
| Discontinued Group (n = 40) | Bridging Group (n = 58) | Continued Group (n = 34) | |
|---|---|---|---|
| Age | 61.0 ± 6.3 | 59.1 ± 8.6 | 62.9 ± 8.6 |
| Male | 20 (50.0) | 32 (55.2) | 16 (47.1) |
| Valve Replace Procedures* | |||
| MVR | 27 (67.5) | 27 (46.6) | 17 (50.0) |
| AVR | 6 (15.0) | 4 (6.9) | 9 (26.5) |
| DVR | 7 (17.5) | 26 (44.8) | 8 (23.5) |
| Concomitant Disease | 28 (70.0) | 32 (55.2) | 24 (70.6) |
| HT | 16 (40.0) | 15 (25.9) | 14 (41.2) |
| DM | 2 (5.0) | 6 (10.3) | 0 |
| HT + DM | 2 (5.0) | 7 (12.1) | 0 |
| CAD | 8 (20.0) | 0 | 4 (11.8) |
| Others | 0 | 4 (6.9) | 6 (17.6) |
| AF | 31 (77.5) | 41 (70.7) | 22 (64.7) |
| Paroxysmal | 6 (15.0) | 8 (13.8) | 7 (20.6) |
| Persistent | 25 (62.5) | 33 (56.9) | 15 (44.1) |
| Pacemaker Replacement | 6 (15.0) | 10 (17.2) | 6 (17.6) |
| Single-Chamber Pacemaker* | 32 (80.0) | 48 (82.8) | 18 (52.9) |
Valve surgery method: MVR = mitral valve replacement; AVR = aortic valve replacement; DVR = mitral + aortic (Double) valve replacement surgery; Concomitant disease: HT = Hypertension; DM = Diabetes Mellitus; CAD = Coronary Artery Disease.
*
Comparison among the three groups, P <0.05.